These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3088326)

  • 21. The enzyme defect in maple syrup urine disease (branched chain ketoaciduria).
    Seegmiller JE; Westall RG
    J Ment Defic Res; 1967 Dec; 11(4):288-94. PubMed ID: 5582930
    [No Abstract]   [Full Text] [Related]  

  • 22. Simple method for rapid quantification of branched-chain 2-oxo acids in physiological fluids as quinoxalinol derivatives by high-performance liquid chromatography.
    Radeck W; Beck K; Staib W
    J Chromatogr; 1988 Nov; 432():297-301. PubMed ID: 3220898
    [No Abstract]   [Full Text] [Related]  

  • 23. A new variant of maple syrup urine disease (branched chain ketoaciduria). Clinical and biochemical evaluation.
    Schulman JD; Lustberg TJ; Kennedy JL; Museles M; Seegmiller JE
    Am J Med; 1970 Jul; 49(1):118-24. PubMed ID: 5431474
    [No Abstract]   [Full Text] [Related]  

  • 24. Quantitative analysis of branched-chain alpha-keto acids as their trimethylsilylated oximes.
    Lancaster G; Lamm P; Scriver CR; Tjoa SS; Mamer OA
    Clin Chim Acta; 1973 Oct; 48(3):279-85. PubMed ID: 4765708
    [No Abstract]   [Full Text] [Related]  

  • 25. Maple syrup urine disease: branched-chain keto-aciduria.
    DANCIS J; LEVITZ M; WESTALL RG
    Pediatrics; 1960 Jan; 25():72-9. PubMed ID: 13813934
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo and in vitro response of human branched chain alpha-ketoacid dehydrogenase to thiamine and thiamine pyrophosphate.
    Danner DJ; Wheeler FB; Lemmon SK; Elsas LJ
    Pediatr Res; 1978 Mar; 12(3):235-8. PubMed ID: 643394
    [No Abstract]   [Full Text] [Related]  

  • 27. Biochemical studies on a variant of branched chain ketoaciduria in a 19-year-old female.
    Fischer MH; Gerritsen T
    Pediatrics; 1971 Nov; 48(5):795-801. PubMed ID: 5125877
    [No Abstract]   [Full Text] [Related]  

  • 28. THE DIAGNOSIS OF MAPLE SYRUP URINE DISEASE (BRANCHED- CHAIN KETOACIDURIA) BY THE IN VITRO STUDY OF THE PERIPHERAL LEUKOCYTE.
    DANCIS J; HUTZLER J; LEVITZ M
    Pediatrics; 1963 Aug; 32():234-8. PubMed ID: 14044451
    [No Abstract]   [Full Text] [Related]  

  • 29. Gas-liquid chromatography of alpha-keto acids: quantification of the branched-chain-alpha-keto acids from physiological sources.
    Cree TC; Hutson SM; Harper AE
    Anal Biochem; 1979 Jan; 92(1):159-63. PubMed ID: 426274
    [No Abstract]   [Full Text] [Related]  

  • 30. [3 patients with maple syrup urine disease].
    Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E
    An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 17-bp insertion and a Phe215----Cys missense mutation in the dihydrolipoyl transacylase (E2) mRNA from a thiamine-responsive maple syrup urine disease patient WG-34.
    Fisher CW; Lau KS; Fisher CR; Wynn RM; Cox RP; Chuang DT
    Biochem Biophys Res Commun; 1991 Jan; 174(2):804-9. PubMed ID: 1847055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiamin-responsive maple syrup urine disease in a patient antigenically missing dihydrolipoamide acyltransferase.
    Ellerine NP; Herring WJ; Elsas LJ; McKean MC; Klein PD; Danner DJ
    Biochem Med Metab Biol; 1993 Jun; 49(3):363-74. PubMed ID: 8347380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
    Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E2 transacylase-deficient (type II) maple syrup urine disease. Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine-responsive phenotype.
    Chuang JL; Cox RP; Chuang DT
    J Clin Invest; 1997 Aug; 100(3):736-44. PubMed ID: 9239422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maple syrup urine disease (branched chain ketoaciduria).
    Harper PA; Healy PJ; Dennis JA
    Am J Pathol; 1990 Jun; 136(6):1445-7. PubMed ID: 2356868
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the clinical picture and pathological anatomy of the maple syrup disease ("branded chain ketoaciduria"). Report on 2 cases in 1 family].
    Sander C; Clotten R; Noetzel H; Wehinger H
    Dtsch Med Wochenschr; 1968 May; 93(18):895-903 passim. PubMed ID: 5650843
    [No Abstract]   [Full Text] [Related]  

  • 37. Mild variant of maple syrup urine disease.
    Kodama S; Seki A; Hanabusa M; Morisita Y; Sakurai T
    Eur J Pediatr; 1976 Dec; 124(1):31-6. PubMed ID: 1001326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical basis of thiamin-responsive maple syrup urine disease.
    Chuang DT; Ku LS; Cox RP
    Trans Assoc Am Physicians; 1982; 95():196-204. PubMed ID: 7182976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlations between branched-chain amino acids and branched-chain alpha-keto acids in blood in maple syrup urine disease.
    Langenbeck U; Wendel U; Mench-Hoinowski A; Kuschel D; Becker K; Przyrembel H; Bremer HJ
    Clin Chim Acta; 1978 Sep; 88(2):283-91. PubMed ID: 699323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination.
    Treacy E; Clow CL; Reade TR; Chitayat D; Mamer OA; Scriver CR
    J Inherit Metab Dis; 1992; 15(1):121-35. PubMed ID: 1583867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.